Comparative effectiveness of abatacept versus tocilizumab in rheumatoid arthritis patients with prior TNFi exposure in the US Corrona registry

BACKGROUND: We compared the effectiveness of abatacept (ABA) vs tocilizumab (TCA) in tumor necrosis factor inhibitor (TNFi) experienced patients. METHODS: We identified rheumatoid arthritis (RA) patients from a large observational US cohort (1 January 2010–31 May 2014) who had discontinued at least...

Descripción completa

Detalles Bibliográficos
Autores principales: Harrold, Leslie R., Reed, George W., Solomon, Daniel H., Curtis, Jeffrey R., Liu, Mei, Greenberg, Jeffrey D., Kremer, Joel M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5134270/
https://www.ncbi.nlm.nih.gov/pubmed/27906048
http://dx.doi.org/10.1186/s13075-016-1179-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5134270/
https://www.ncbi.nlm.nih.gov/pubmed/27906048
http://dx.doi.org/10.1186/s13075-016-1179-7

Ejemplares similares